Thrombocytopenia - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Thrombocytopenia

Description:

Thrombocytopenia Dr S W Bokhari Consultant Haematologist University Hospital Coventry and Warwickshire Thrombocytopenia You are the Surgical HO asked to clerk patient ... – PowerPoint PPT presentation

Number of Views:813
Avg rating:3.0/5.0
Slides: 35
Provided by: Mil5167
Category:

less

Transcript and Presenter's Notes

Title: Thrombocytopenia


1
  • Thrombocytopenia
  • Dr S W Bokhari
  • Consultant Haematologist
  • University Hospital Coventry and Warwickshire

2
Thrombocytopenia
  • You are the Surgical HO asked to clerk patient on
    ward pre-operatively prior to hernia repair.
  • You notice from results on CRRS that his platelet
    count one week earlier was 25. No previous
    results.
  • How do you approach this problem?

3
  • Repeat FBC
  • Hb 13g/dL WCC 8 Neuts 2.5 Plts 28 MCV 102
  • Ask for blood film to be reviewed
  • Film comment confirmed thrombocytopenia, normal
  • platelet morphology mild macrocytosis no other
    abnormal
  • features
  • Inform surgeons/theatres etc

4
Peripheral blood film
5
Platelet clumping
6
History
  • 40 year old man
  • Symptoms
  • Bleeding history severity and duration
  • Recent illness including infections esp. viral
  • Patient had noticed easy bruising for previous 2
    months.
  • Fit and well with no recent illness

7
Mucosal bleeding
8
Purpura
9
Past Medical History
  • Infections bacterial, viral, fungal
  • Autoimmune disease
  • Liver disease
  • Malignancy
  • Occasional backpain
  • Road traffic accident 5 years ago following which
    he
  • received blood transfusion

10
Family History
  • Congenital causes of thrombocytopenia
  • Autoimmune disease
  • Mother IDDM
  • Sister recently diagnosed with SLE

11
Drug History
  • Long list to consider!
  • -immune-mediated
  • -direct effect on BM or MK
  • Alcohol intake
  • Takes diclofenac for backpain
  • 30 units alcohol per week spirits
  • Smokes 15/day

12
Social History
  • Occupation - ? Exposure to toxic agents
  • Dietary history
  • Recent travel abroad infections
  • Risk factors for HIV
  • Recently made redundant having previously worked
    in
  • motor industry
  • No recent travel abroad
  • No risk factors for HIV

13
Examination
  • Bleeding/bruising
  • Anaemia
  • Clubbing/jaundice (other features of CLD)
  • Lymphadenopathy
  • Signs of malignancy
  • Hepatomegaly
  • Splenomegaly
  • Features associated with congenital causes esp.
    Fanconi
  • anaemia

14
  • Bruising over arms and legs
  • ? Yellow sclera
  • Liver palpable 3cm
  • No other findings

15
Investigations
  • FBC
  • Pancytopenia or isolated thrombocytopenia
  • MCV
  • Blood film
  • Confirm thrombocytopenia
  • Platelet size and morphology
  • Red cell fragments
  • Red cell abnormalities e.g. target cells
  • WBC features

16
Giant platelets
17
Red cell fragments
18
Target cells
19
Hypersegmented neutrophil
20
  • Hb 13g/dL WCC 5 Neuts 2.0 Plts 28 MCV 102
  • Target cells and stomatocytes

21
  • Renal function
  • Liver function
  • B12 and folate
  • Full clotting screen
  • Normal renal function
  • AST 160 Alk phos 170 ALT 130 Bili 60 ?GT 100
  • B12 110 Folate 1.4
  • PT ratio 1.6 APTT ratio 1.4 Normal fibrinogen and
    TT

22
  • Autoantibody screen specific autoantibodies as
    indicated
  • Antiphospholipid antibodies
  • Lupus anticoagulant
  • Anticardiolipin antibodies
  • Autoantibodies screen negative
  • Antiphospholipid antibodies positive

23
  • Virology testing
  • EBV, CMV, toxoplasma
  • Hep B, C
  • HIV
  • Hepatitis C positive
  • Presumed secondary to blood transfusion

24
Causes of thrombocytopenia
  • Failure of production
  • Increased consumption/destruction
  • Abnormal pooling - splenomegaly

25
Failure of production
  • Congenital
  • Fanconi anaemia, TAR (thrombocytopenia with
    absent
  • radii), Wiskott-Aldrich syndrome, Bernard-Soulier
    synd.,
  • May-Hegglin anomaly, Alport synd. variant, Grey
    platelet
  • synd.
  • Acquired specific thrombocytopenia
  • Infection esp. viral
  • Nutritional deficiency B12/folate
  • Toxic effect of drugs (more often immune) or
    alcohol

26
Failure of production
  • Acquired as part of bone marrow failure
  • Drugs including chemotherapy
  • Radiotherapy
  • Marrow infiltration malignant/non-malignant
  • Aplastic anaemia

27
Bone marrow aspirate
28
Bone marrow trephine
29
Increased destruction of platelets
  • Immune
  • Idiopathic
  • ITP (acute and chronic)
  • Secondary
  • Autoimmune disease e.g. SLE
  • Infections e.g. HIV, Hepatitis C
  • Drugs e.g. heparin (HIT), quinine, quinidine,
    gold salts
  • Lymphoproliferative disease e.g. CLL
  • Neonatal alloimmune thrombocytopenia
  • Post-transfusion purpura

30
Increased destruction of platelets
  • Non-immune
  • Microangiopathic haemolytic anaemia (MAHA)
  • DIC
  • HUS
  • TTP idiopathic or 2ยบ e.g. pregnancy,
    infection, metastatic carcinoma, drugs, BMT, AI
    disease
  • Pregnancy related
  • Gestational thrombocytopenia
  • Preeclampsia
  • HELLP

31
Management
  • Few spontaneous bleeding problems if plts gt 30
  • Unless
  • Abnormal platelet function
  • Associated coagulopathy
  • In general patients need treatment if symptomatic
    or increased risk of bleeding e.g.
    peri/post-operatively, trauma, obstetric
  • In general would want platelets gt 50 for minor op
    and gt80/100 for major op.
  • May need to transfuse plts if count higher but
    abnormal function

32
Management
  • May need bone marrow to determine whether cause
    of thrombocytopenia is failure of production or
    increased destruction
  • Stop any possible implicated drugs
  • In general if failure of production
  • Platelet transfusions
  • Treat underlying cause e.g. B12/folate
    replacement

33
Management
  • In general if increased destruction
  • Avoid platelet transfusions as these are often
    ineffective and can make clinical situation worse
    e.g. TTP, HIT
  • Exception - DIC
  • May be required if life-threatening bleeding
    e.g. ITP
  • Treat underlying cause e.g. CLL
  • ITP
  • Immunosuppression steroids, IVIG, other
    immunosuppressive agents
  • Splenectomy

34
Management
  • TTP-HUS may require plasma exchange/FFP
  • NAIT/PTP may require HPA1A neg plts
Write a Comment
User Comments (0)
About PowerShow.com